These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 35384360)
1. Essential role of membrane vesicles for biological activity of the bacteriocin micrococcin P1. Liu Y; Liu Q; Zhao L; Dickey SW; Wang H; Xu R; Chen T; Jian Y; Wang X; Lv H; Otto M; Li M J Extracell Vesicles; 2022 Apr; 11(4):e12212. PubMed ID: 35384360 [TBL] [Abstract][Full Text] [Related]
2. A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model. Ovchinnikov KV; Kranjec C; Telke A; Kjos M; Thorstensen T; Scherer S; Carlsen H; Diep DB Front Immunol; 2021; 12():676534. PubMed ID: 34276663 [TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis of Bacteriocin-Producing Staphylococci: High Prevalence of Lanthipeptides and the Micrococcin P1 Biosynthetic Gene Clusters. Fernández-Fernández R; Elsherbini AMA; Lozano C; Martínez A; de Toro M; Zarazaga M; Peschel A; Krismer B; Torres C Probiotics Antimicrob Proteins; 2023 Aug; ():. PubMed ID: 37632676 [TBL] [Abstract][Full Text] [Related]
4. Horizontal Transfer of Bacteriocin Biosynthesis Genes Requires Metabolic Adaptation To Improve Compound Production and Cellular Fitness. Krauss S; Harbig TA; Rapp J; Schaefle T; Franz-Wachtel M; Reetz L; Elsherbini AMA; Macek B; Grond S; Link H; Nieselt K; Krismer B; Peschel A; Heilbronner S Microbiol Spectr; 2023 Feb; 11(1):e0317622. PubMed ID: 36472430 [TBL] [Abstract][Full Text] [Related]
5. Dean SN; Rimmer MA; Turner KB; Phillips DA; Caruana JC; Hervey WJ; Leary DH; Walper SA Front Microbiol; 2020; 11():710. PubMed ID: 32425905 [TBL] [Abstract][Full Text] [Related]
6. A New Thiopeptide Antibiotic, Micrococcin P3, from a Marine-Derived Strain of the Bacterium Wang W; Park KH; Lee J; Oh E; Park C; Kang E; Lee J; Kang H Molecules; 2020 Sep; 25(19):. PubMed ID: 32987657 [TBL] [Abstract][Full Text] [Related]
7. Diversified transporters and pathways for bacteriocin secretion in gram-positive bacteria. Zheng S; Sonomoto K Appl Microbiol Biotechnol; 2018 May; 102(10):4243-4253. PubMed ID: 29560521 [TBL] [Abstract][Full Text] [Related]
8. Staphylococcus epidermidis bacteriocin A37 kills natural competitors with a unique mechanism of action. Puls JS; Winnerling B; Power JJ; Krüger AM; Brajtenbach D; Johnson M; Bilici K; Camus L; Fließwasser T; Schneider T; Sahl HG; Ghosal D; Kubitscheck U; Heilbronner S; Grein F ISME J; 2024 Jan; 18(1):. PubMed ID: 38470311 [TBL] [Abstract][Full Text] [Related]
9. Membrane vesicles from antibiotic-resistant Staphylococcus aureus transfer antibiotic-resistance to antibiotic-susceptible Escherichia coli. Lee AR; Park SB; Kim SW; Jung JW; Chun JH; Kim J; Kim YR; Lazarte JMS; Jang HB; Thompson KD; Jung M; Ha MW; Jung TS J Appl Microbiol; 2022 Apr; 132(4):2746-2759. PubMed ID: 35019198 [TBL] [Abstract][Full Text] [Related]
11. Inhibiting bacterial colonization on catheters: Antibacterial and antibiofilm activities of bacteriocins from Lactobacillus plantarum SJ33. Ray Mohapatra A; Jeevaratnam K J Glob Antimicrob Resist; 2019 Dec; 19():85-92. PubMed ID: 30853461 [TBL] [Abstract][Full Text] [Related]
12. Bacteriocin as weapons in the marine animal-associated bacteria warfare: inventory and potential applications as an aquaculture probiotic. Desriac F; Defer D; Bourgougnon N; Brillet B; Le Chevalier P; Fleury Y Mar Drugs; 2010 Apr; 8(4):1153-77. PubMed ID: 20479972 [TBL] [Abstract][Full Text] [Related]
13. A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms. Kranjec C; Ovchinnikov KV; Grønseth T; Ebineshan K; Srikantam A; Diep DB NPJ Biofilms Microbiomes; 2020 Dec; 6(1):58. PubMed ID: 33268776 [TBL] [Abstract][Full Text] [Related]
14. Bacteriocin PJ4 active against enteric pathogen produced by Lactobacillus helveticus PJ4 isolated from gut microflora of wistar rat (Rattus norvegicus): partial purification and characterization of bacteriocin. Jena PK; Trivedi D; Chaudhary H; Sahoo TK; Seshadri S Appl Biochem Biotechnol; 2013 Apr; 169(7):2088-100. PubMed ID: 23371780 [TBL] [Abstract][Full Text] [Related]
16. Epidemiological dynamics of bacteriocin competition and antibiotic resistance. Lehtinen S; Croucher NJ; Blanquart F; Fraser C Proc Biol Sci; 2022 Oct; 289(1984):20221197. PubMed ID: 36196547 [TBL] [Abstract][Full Text] [Related]
17. Bacteriocin-Based Synergetic Consortia: a Promising Strategy to Enhance Antimicrobial Activity and Broaden the Spectrum of Inhibition. Soltani S; Biron E; Ben Said L; Subirade M; Fliss I Microbiol Spectr; 2022 Feb; 10(1):e0040621. PubMed ID: 35170996 [TBL] [Abstract][Full Text] [Related]
18. The Contribution of Membrane Vesicles to Bacterial Pathogenicity in Cystic Fibrosis Infections and Healthcare Associated Pneumonia. Vitse J; Devreese B Front Microbiol; 2020; 11():630. PubMed ID: 32328052 [TBL] [Abstract][Full Text] [Related]
19. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria. Chi H; Holo H Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043 [TBL] [Abstract][Full Text] [Related]